How to use Safely COVID-19 Vaccines in Patients on Anticoagulants or Antiaggregants
Keywords:
....Abstract
Dear editor,
The current pandemic affected the lives of billions of individuals. The correlation between COVID-19 and cardiovascular diseases has also been documented in clinical studies. This is especially valid for patients with pre-existing cardiovascular conditions who are more prone to severe COVID-19, poorer outcomes, and elevated risk of hospitalizations and death.1 COVID-19 itself can also cause cardiac damage with the respective manifestations mainly affecting pericardium/ myocardium, as well as vascular damage (arterial and venous), primarily causing endothelial dysfunction. The latter is observed not only in the pulmonary circulation but also in other organs. Cardiac and vascular damage are associated with various well-observed and established complications. In line with this, COVID-19 vaccines are strongly recommended to patients with Cardiovascular Diseases (CVDs).
How to cite this article:
Velikov T, Keremidchiev G, Velikova T. How to use Safely COVID-19 Vaccines in Patients on Anticoagulants or Antiaggregants. Int J Preven Cardio 2021; 1(1): 32-33.
References
Nishiga M, Wang DW, Han Y et al. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat Rev Cardiol 2020; 17; 543-558. From: https://doi.org/10.1038/s41569-020-0413-9
Casajuana J, Iglesias B, Fàbregas M et al. Safety of intramuscular influenza vaccine in patients receiving
oral anticoagulation therapy: a single-blinded multicenter randomized controlled clinical trial. BMC Blood Disord 2008; 8: 1. Published 2008 May 29. DOI:10.1186/1471-2326-8-1
COVID-19: the green book, chapter 14a. Ref: PHE gateway number 2020300. Last access on 28/01/2021 at https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/955548/Greenbook_chapter_14a_v6.pdf
Downloads
Published
Issue
Section
License
Copyright (c) 2021 International Journal of Preventive Cardiology
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
We, the undersigned, give an undertaking to the following effect with regard to our article entitled
“_______________________________________________________________________________________________________________________________________________________________________________
________________________________________________________________________________” submitted for publication in (Journal title)________________________________________________ _______________________________________________________Vol.________, Year _________:-
1. The article mentioned above has not been published or submitted to or accepted for publication in any form, in any other journal.
2. We also vouchsafe that the authorship of this article will not be contested by anyone whose name(s) is/are not listed by us here.
3. I/We declare that I/We contributed significantly towards the research study i.e., (a) conception, design and/or analysis and interpretation of data and to (b) drafting the article or revising it critically for important intellectual content and on (c) final approval of the version to be published.
4. I/We hereby acknowledge ADRs conflict of interest policy requirement to scrupulously avoid direct and indirect conflicts of interest and, accordingly, hereby agree to promptly inform the editor or editor's designee of any business, commercial, or other proprietary support, relationships, or interests that I/We may have which relate directly or indirectly to the subject of the work.
5. I/We also agree to the authorship of the article in the following sequence:-
Authors' Names (in sequence) Signature of Authors
1. _____________________________________ _____________________________________
2. _____________________________________ _____________________________________
3. _____________________________________ _____________________________________
4. _____________________________________ _____________________________________
5. _____________________________________ _____________________________________
6. _____________________________________ _____________________________________
7. _____________________________________ _____________________________________
8. _____________________________________ _____________________________________
Important
(I). All the authors are required to sign independently in this form in the sequence given above. In case an author has left the institution/ country and whose whereabouts are not known, the senior author may sign on his/ her behalf taking the responsibility.
(ii). No addition/ deletion/ or any change in the sequence of the authorship will be permissible at a later stage, without valid reasons and permission of the Editor.
(iii). If the authorship is contested at any stage, the article will be either returned or will not be
processed for publication till the issue is solved.
